CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit

robot
Abstract generation in progress

The Rosen Law Firm is reminding purchasers of Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024, and December 30, 2025, of the April 21, 2026, deadline to serve as lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Corcept misrepresented the support for its New Drug Application (NDA) for relacorilant with the FDA, leading investors to suffer damages when the truth about the FDA’s concerns became known. Investors who bought Corcept stock during this period may be entitled to compensation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments